MSLN and mesothelioma: However, mesothelin as an individual biomarker is characterized by a high specificity of 89% (95% CI 86; 91%) but a relatively low sensitivity of 58% (95% CI 54; 62%) for the discrimination of mesothelioma patients and asbestos exposed subjects as recently shown in a meta-analysis [15].